Eugenia Migliavacca

Title: Eugenia Migliavacca: Innovator in Muscle Disease Research

Introduction

Eugenia Migliavacca is a prominent inventor based in Lausanne, Switzerland. She has made significant contributions to the field of muscle disease, particularly in understanding sarcopenia and NAD deficiency. Her innovative work has the potential to impact the way we approach nutritional interventions for individuals at risk of muscle-related conditions.

Latest Patents

Eugenia holds a patent titled "Methods to predict risk of and to stratify sarcopenia and NAD deficiency." This invention relates to a method for determining if a subject has sarcopenia or is at an increased risk of developing this condition. Additionally, her patent provides a method for predicting the responsiveness of subjects to nutritional interventions, which could lead to more effective treatment strategies.

Career Highlights

Throughout her career, Eugenia has worked with esteemed institutions such as the University of Southampton and the Agency for Science, Technology and Research. Her experience in these organizations has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Eugenia has collaborated with Jerome Feige, enhancing her research efforts and expanding the impact of her work in muscle disease.

Conclusion

Eugenia Migliavacca's innovative contributions to the understanding of sarcopenia and NAD deficiency highlight her role as a key figure in muscle disease research. Her patent and collaborations reflect her commitment to advancing medical science and improving patient outcomes.